These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9829633)

  • 21. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
    Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
    Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies.
    Lee JW; Kim Km; Jung SH; Lee KJ; Choi EC; Sung YC; Kang CY
    J Virol; 1999 Jan; 73(1):11-8. PubMed ID: 9847301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of HCV core mimotopes: improved methods for the selection and use of disease-related phage-displayed peptides.
    Tafi R; Bandi R; Prezzi C; Mondelli MU; Cortese R; Monaci P; Nicosia A
    Biol Chem; 1997 Jun; 378(6):495-502. PubMed ID: 9224929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
    Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
    Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
    Cerino A; Mondelli MU
    J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
    Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
    J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis.
    Reddy AK; Dakshinamurty KV; Lakshmi V
    Indian J Med Microbiol; 2006 Jan; 24(1):55-7. PubMed ID: 16505558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic structure of the hepatitis C virus envelope 2 protein.
    Zhang ZX; Sönnerborg A; Sällberg M
    Clin Exp Immunol; 1994 Dec; 98(3):382-7. PubMed ID: 7527739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
    Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
    J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
    Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
    J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial cell surface display for epitope mapping of hepatitis C virus core antigen.
    Kang SM; Rhee JK; Kim EJ; Han KH; Oh JW
    FEMS Microbiol Lett; 2003 Sep; 226(2):347-53. PubMed ID: 14553932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.